Particle.news

Finger-Prick Dried Blood Test Flags Alzheimer’s Biomarkers in European Study

Early data show roughly 86% agreement with reference measures; larger, standardized trials remain necessary.

Overview

  • The method uses a single capillary drop dried on paper cards, enabling simple shipping by mail without refrigeration.
  • In 337 participants across seven European centers, p‑tau217 from finger-prick samples closely matched venous blood and cerebrospinal fluid assessments.
  • GFAP and NfL were also measured reliably from dried samples, showing strong concordance with conventional diagnostics.
  • Many volunteers performed the collection without clinical supervision, indicating feasible self-sampling for remote or large-scale screening.
  • Findings included a Down syndrome subgroup, which showed higher p‑tau217 and GFAP levels consistent with established Alzheimer risk profiles.